Ray Dalio
BIO icon

Ray Dalio’s Bio-Rad Laboratories Class A BIO Stock Holding History

Ray Dalio’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-1,684
Closed -$469K – 1027
2026
Q1 		$469K Buy
+1,684
New +$485K ﹤0.01% 894
2025
Q4 		– Sell
-10,632
Closed -$2.98M – 1064
2025
Q3 		$2.98M Buy
+10,632
New +$2.89M 0.01% 623
2024
Q1 		– Sell
-771
Closed -$249K – 701
2023
Q4 		$249K Sell
771
-15,988
-95% -$5.01M ﹤0.01% 736
2023
Q3 		$6.01M Buy
16,759
+290
+2% +$112K 0.04% 326
2023
Q2 		$6.24M Buy
16,469
+15,666
+1,951% +$6.38M 0.04% 263
2023
Q1 		$385K Sell
803
-11,171
-93% -$5.23M ﹤0.01% 667
2022
Q4 		$5.03M Buy
11,974
+3,563
+42% +$1.44M 0.03% 358
2022
Q3 		$3.51M Buy
8,411
+5,178
+160% +$2.58M 0.02% 454
2022
Q2 		$1.6M Buy
3,233
+2,848
+740% +$1.48M 0.01% 723
2022
Q1 		$217K Buy
+385
New +$232K ﹤0.01% 958
2019
Q1 		– Sell
-6,590
Closed -$1.53M – 335
2018
Q4 		$1.53M Buy
6,590
+4,574
+227% +$1.23M 0.01% 281
2018
Q3 		$631K Buy
2,016
+184
+10% +$57.1K 0.01% 262
2018
Q2 		$529K Sell
1,832
-1,777
-49% -$491K 0.01% 358
2018
Q1 		$903K Sell
3,609
-15,646
-81% -$3.98M 0.01% 282
2017
Q4 		$4.6M Buy
+19,255
New +$4.67M 0.04% 91
2015
Q4 		– Sell
-2,978
Closed -$400K – 290
2015
Q3 		$400K Buy
+2,978
New +$429K 0.01% 367

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ariel Investments
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Ray Dalio's BIO Position: Q2 2026 in Review

Ray Dalio sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2026, closing a stake of 1,684 shares — an estimated $469K sold.

Ray Dalio first reported a position in BIO in Q3 2015 and held it in 16 quarters. The position peaked at $6.24M in Q2 2023. 401 funds tracked by Wall St. Rank hold BIO as of Q2 2026.

  • Ray Dalio reported no remaining Bio-Rad Laboratories Class A position as of Q2 2026 after selling out during the quarter.
  • Ray Dalio sold 1,684 Bio-Rad Laboratories Class A shares in Q2 2026, an estimated $469K.
  • Ray Dalio first reported a position in Bio-Rad Laboratories Class A in Q3 2015 and held it in 16 quarters.
  • Ray Dalio's Bio-Rad Laboratories Class A position peaked at $6.24M in Q2 2023.
  • 401 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.